scPharmaceuticals Inc expected to post a loss of 34  cents a share - Earnings Preview

Scpharmaceuticals

18/03/2022 12:57

* scPharmaceuticals Inc  SCPH.OQ   SCPH.O  is expected
to show no
change in quarterly revenue when it reports  results on March 21
(estimated). 
    * ​Refinitiv's mean analyst estimate for scPharmaceuticals
Inc is
for a loss of 34 cents per share. For the same quarter last
year, the company reported a loss of 28 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for
scPharmaceuticals
Inc is $11​, above​ its last closing price of $5.21. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  -0.31       -0.31      -0.24     Beat    23.4
 Jun. 30 2021  -0.30       -0.30      -0.26     Beat    13.3
 Mar. 31 2021  -0.30       -0.30      -0.26     Beat    13.3​
 Dec. 31 2020  -0.36       -0.36      -0.28     Beat    22.9
 ​​Sep.        -0.38       -0.38      -0.33     Beat    13.7
 30 2020                                                
 Jun. 30 2020  -0.42       -0.42      -0.36     Beat    14.8​
 Mar. 31 2020  -0.53       -0.54      -0.35     Beat    34.9
 Dec. 31 2019              -0.52      -0.58     Missed  -10.5
 This summary was machine generated March 18 at 12:57 GMT.  All
figures in US dollars  unless otherwise stated